Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm

Osama A. Abulseoud, Joseph D. Miller, Jinhua Wu, Doo Sup Choi, Daniel P. Holschneider

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Glutamate signaling plays an essential role in drug-seeking behavior. Using reinstatement of conditioned place preference (CPP), we determined whether ceftriaxone, a β-lactam antibiotic known to increase the expression and activity of the glutamate transporter (EAAT 2) on glial cells, blocks methamphetamine-triggered reinstatement of CPP. Rats acquired methamphetamine CPP following 7 consecutive days of conditioning, during which each animal received pairings of alternating morning methamphetamine (2.5 mg/kg, IP) and afternoon saline (IP). Animals showing CPP were successfully extinguished with repeated twice daily saline administration over a 7-day period. Ceftriaxone (200 mg/kg, IP) was administered (vs. saline) once a day for 7 days during the extinction period. Upon successful extinction, animals received a single dose of methamphetamine (2.5 mg/kg, IP) for reinstatement and were tested for CPP one day later. Using real time PCR, EAAT 2 mRNA levels in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) were quantified in response to ceftriaxone. Ceftriaxone blocked methamphetamine-triggered reinstatement of CPP and significantly increased EAAT 2 mRNA levels in the mPFC, with a trend towards significance in the NAc. In conclusion, Ceftriaxone modulated the expression of the glutamate transporter in a critical region of the cortico-striatal addiction circuitry and attenuated drug-seeking behavior in rats. Further research is needed to test the efficacy of compounds targeting the EAAT 2 in human methamphetamine-dependent users.

Original languageEnglish (US)
Pages (from-to)14-21
Number of pages8
JournalBrain Research
Volume1456
DOIs
StatePublished - May 25 2012

Fingerprint

Amino Acid Transport System X-AG
Methamphetamine
Ceftriaxone
Prefrontal Cortex
Up-Regulation
Drug-Seeking Behavior
Nucleus Accumbens
Corpus Striatum
Lactams
Messenger RNA
Neuroglia
Real-Time Polymerase Chain Reaction
Glutamic Acid
Anti-Bacterial Agents
Research

Keywords

  • Addiction
  • Ceftriaxone
  • Conditioned place preference
  • Excitatory amino acid transporter
  • Glutamate
  • Glutamate transporter
  • Methamphetamine
  • Relapse

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. / Abulseoud, Osama A.; Miller, Joseph D.; Wu, Jinhua; Choi, Doo Sup; Holschneider, Daniel P.

In: Brain Research, Vol. 1456, 25.05.2012, p. 14-21.

Research output: Contribution to journalArticle

@article{cadd61e6b7d54e9d9a861f582dc905a1,
title = "Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm",
abstract = "Glutamate signaling plays an essential role in drug-seeking behavior. Using reinstatement of conditioned place preference (CPP), we determined whether ceftriaxone, a β-lactam antibiotic known to increase the expression and activity of the glutamate transporter (EAAT 2) on glial cells, blocks methamphetamine-triggered reinstatement of CPP. Rats acquired methamphetamine CPP following 7 consecutive days of conditioning, during which each animal received pairings of alternating morning methamphetamine (2.5 mg/kg, IP) and afternoon saline (IP). Animals showing CPP were successfully extinguished with repeated twice daily saline administration over a 7-day period. Ceftriaxone (200 mg/kg, IP) was administered (vs. saline) once a day for 7 days during the extinction period. Upon successful extinction, animals received a single dose of methamphetamine (2.5 mg/kg, IP) for reinstatement and were tested for CPP one day later. Using real time PCR, EAAT 2 mRNA levels in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) were quantified in response to ceftriaxone. Ceftriaxone blocked methamphetamine-triggered reinstatement of CPP and significantly increased EAAT 2 mRNA levels in the mPFC, with a trend towards significance in the NAc. In conclusion, Ceftriaxone modulated the expression of the glutamate transporter in a critical region of the cortico-striatal addiction circuitry and attenuated drug-seeking behavior in rats. Further research is needed to test the efficacy of compounds targeting the EAAT 2 in human methamphetamine-dependent users.",
keywords = "Addiction, Ceftriaxone, Conditioned place preference, Excitatory amino acid transporter, Glutamate, Glutamate transporter, Methamphetamine, Relapse",
author = "Abulseoud, {Osama A.} and Miller, {Joseph D.} and Jinhua Wu and Choi, {Doo Sup} and Holschneider, {Daniel P.}",
year = "2012",
month = "5",
day = "25",
doi = "10.1016/j.brainres.2012.03.045",
language = "English (US)",
volume = "1456",
pages = "14--21",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm

AU - Abulseoud, Osama A.

AU - Miller, Joseph D.

AU - Wu, Jinhua

AU - Choi, Doo Sup

AU - Holschneider, Daniel P.

PY - 2012/5/25

Y1 - 2012/5/25

N2 - Glutamate signaling plays an essential role in drug-seeking behavior. Using reinstatement of conditioned place preference (CPP), we determined whether ceftriaxone, a β-lactam antibiotic known to increase the expression and activity of the glutamate transporter (EAAT 2) on glial cells, blocks methamphetamine-triggered reinstatement of CPP. Rats acquired methamphetamine CPP following 7 consecutive days of conditioning, during which each animal received pairings of alternating morning methamphetamine (2.5 mg/kg, IP) and afternoon saline (IP). Animals showing CPP were successfully extinguished with repeated twice daily saline administration over a 7-day period. Ceftriaxone (200 mg/kg, IP) was administered (vs. saline) once a day for 7 days during the extinction period. Upon successful extinction, animals received a single dose of methamphetamine (2.5 mg/kg, IP) for reinstatement and were tested for CPP one day later. Using real time PCR, EAAT 2 mRNA levels in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) were quantified in response to ceftriaxone. Ceftriaxone blocked methamphetamine-triggered reinstatement of CPP and significantly increased EAAT 2 mRNA levels in the mPFC, with a trend towards significance in the NAc. In conclusion, Ceftriaxone modulated the expression of the glutamate transporter in a critical region of the cortico-striatal addiction circuitry and attenuated drug-seeking behavior in rats. Further research is needed to test the efficacy of compounds targeting the EAAT 2 in human methamphetamine-dependent users.

AB - Glutamate signaling plays an essential role in drug-seeking behavior. Using reinstatement of conditioned place preference (CPP), we determined whether ceftriaxone, a β-lactam antibiotic known to increase the expression and activity of the glutamate transporter (EAAT 2) on glial cells, blocks methamphetamine-triggered reinstatement of CPP. Rats acquired methamphetamine CPP following 7 consecutive days of conditioning, during which each animal received pairings of alternating morning methamphetamine (2.5 mg/kg, IP) and afternoon saline (IP). Animals showing CPP were successfully extinguished with repeated twice daily saline administration over a 7-day period. Ceftriaxone (200 mg/kg, IP) was administered (vs. saline) once a day for 7 days during the extinction period. Upon successful extinction, animals received a single dose of methamphetamine (2.5 mg/kg, IP) for reinstatement and were tested for CPP one day later. Using real time PCR, EAAT 2 mRNA levels in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) were quantified in response to ceftriaxone. Ceftriaxone blocked methamphetamine-triggered reinstatement of CPP and significantly increased EAAT 2 mRNA levels in the mPFC, with a trend towards significance in the NAc. In conclusion, Ceftriaxone modulated the expression of the glutamate transporter in a critical region of the cortico-striatal addiction circuitry and attenuated drug-seeking behavior in rats. Further research is needed to test the efficacy of compounds targeting the EAAT 2 in human methamphetamine-dependent users.

KW - Addiction

KW - Ceftriaxone

KW - Conditioned place preference

KW - Excitatory amino acid transporter

KW - Glutamate

KW - Glutamate transporter

KW - Methamphetamine

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=84860638271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860638271&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2012.03.045

DO - 10.1016/j.brainres.2012.03.045

M3 - Article

C2 - 22521042

AN - SCOPUS:84860638271

VL - 1456

SP - 14

EP - 21

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -